Clarivate Plc will participate in the 16th annual Pharmavision India conference on September 3, 2025, at the Taj Krishna in Hyderabad. The event will focus on how Indian pharmaceutical companies can capture new growth in generics and biosimilars amid shifting market dynamics. Clarivate will leverage its proprietary data and insights to facilitate discussions on innovation, regulatory change, market access, and supply chain resilience, aiming to help participants identify emerging opportunities and strategies for sustainable growth.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clarivate plc published the original content used to generate this news brief on September 01, 2025, and is solely responsible for the information contained therein.